JAK2/STAT5 | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

2,110 results for “JAK2/STAT5”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

PCM1-JAK2 in Therapy Related Neoplasms

140 participants · First posted May 9, 2019

Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis

12 participants · First posted Nov 25, 2025

JAK2 Inhibitors RUXOLITINIB in Patients With Myelofibrosis

78 participants · First posted Feb 21, 2013

Anticoagulation in Gastroesophageal Varices and JAK2 Mutation

40 participants · First posted Aug 26, 2020

Active, not recruiting

Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis

15 participants · First posted Aug 18, 2020

Characterization of JAK1 and JAK2 Activation in Gingival Tissues During Homeostasis and Periodontitis

30 participants · First posted Apr 17, 2026

Dual PD-1 and JAK2 Inhibition in Hematological Malignancies

First posted Jul 11, 2019

JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil

25 participants · First posted May 1, 2026

Combination of JAK2 Inhibitor and Erythropoiesis-stimulating Agent in Myelofibrosis

65 participants · First posted Jul 6, 2017

Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation

39 participants · First posted Dec 8, 2014

Page 1 of 152